Optimizing Patient Engagement in a Novel Pain Management Initiative (OPEN) (OPENtext)
Descripción general del estudio
Descripción detallada
Chronic pain is a condition that affects the most fundamental aspects of quality of life. Treatment for chronic pain is challenging and usually takes the form of opioid medication therapy. But chronic opioid therapy is also associated with high rates of emergency department use, drug diversion, addiction, and unintentional overdose deaths. The new RI Medicaid Chronic Pain Initiative (CPI) targets patients who are both high emergency department users and experiencing chronic pain. In the CPI, patients can be prescribed an integrated treatment plan of massage, chiropractic, or acupuncture therapies. This is a novel approach to chronic pain care, but retention and patient engagement are low. It is important to understand why involvement in the CPI is low, how to improve the patient experience, and how to support the prescribed CAM therapies.
This study has two aims: The first is to identify what helps to keep patients involved with the CPI program and to identify features of an ideal text-message-based program for people enrolled in the CPI. The second aim is to develop the text-message-based program (OPENtext), then find out how useful this intervention is compared to a patient navigator intervention (OPENnav) for increasing patient engagement, improving patient's motivation to manage their chronic pain, and improving patient confidence in self-managing their chronic pain condition.
Investigators will conduct qualitative interviews with patients, providers, and administrators. Goals of the interviews will be: to understand the patient experience in the CPI, including experiences with the navigation approach currently in place; to identify barriers and facilitators to CPI participation; and to learn how technology-especially cell phone text-messaging-could help support pain care and CPI engagement. These interviews will help develop a text-message-based intervention and provide feedback to existing patient navigator programming. Next, investigators will develop and test the text-message patient support intervention that will contain patient-identified topics and concerns that emerge from the qualitative interviews and topic areas discussed by a stakeholder Advisory Board. Theories of behavior change will be used to help with message development, and patients will take part in helping to test and fine-tune the intervention. Last, investigators will compare the text-message and patient navigation interventions in a randomized controlled study with 200 patients over a six-month period. Investigators will see which approach helps patients increase their involvement in the CPI and better manage their chronic pain. If successful, chronic pain patients across Medicaid programs could benefit from use of the patient navigation or the text-message intervention.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Rhode Island
-
Providence, Rhode Island, Estados Unidos, 02903
- Rhode Island Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Enrolled in the Rhode Island Medicaid Chronic Pain Initiative program
Exclusion Criteria:
- Do not speak English
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: OPENtext
OPENtext will target cognitive, affective, and behavioral strategies through a single, brief in-person assessment, followed by 12 weeks of theoretically-informed text messages, a core set of information organized in a 'frequently asked questions' structure, interactive peer support, static resources on key patient-identified topics, and a library of peer stories accessible throughout the study period.
|
Participants will receive 12 weeks of daily text messages sent from an automated system.
The text messages will assist participants in managing their chronic pain.
|
|
Comparador activo: OPENnav
Peer Navigation is currently offered to some individuals in this Medicaid population but not all.
Peer navigators interact with patients by phone/text and at home visits.
Efforts focus on drivers of a patient's ED use, and may include providing or identifying patient support, improving health literacy, assisting with transportation vouchers, health education, family support, accessing housing services, and orienting to other community support services.
|
Particpants will be linked with a RIPN PEER Navigator who will assisted them in managing their health care
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Engagement
Periodo de tiempo: Once per month for 6 months
|
Investigators will capture change in engagement in the CPI program based on utilization of services per month, derived from AMI's administrative records.
For the purposes of this study, engagement will be defined as having one or more visits to a CAM provider in a given month.
|
Once per month for 6 months
|
|
Readiness to Change
Periodo de tiempo: At baseline, 3 months, and 6 months post-randomization
|
The Pain Stages of Change Questionnaire (PSOCQ) will be used to measure change in patient's self-reported engagement in the CPI and in the intervention group.
|
At baseline, 3 months, and 6 months post-randomization
|
|
Change in Self-Efficacy
Periodo de tiempo: At baseline, 3 months, and 6 months post-randomization
|
To measure patient's change in confidence of their ability to self-manage their condition, investigators will use the Chronic Pain Self Efficacy Scale (CPSS).
|
At baseline, 3 months, and 6 months post-randomization
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Pain Severity
Periodo de tiempo: At baseline, 3 months, and 6 months post-randomization
|
To assess the severity of pain and the impact of pain on daily functions, investigators will use the Brief Pain Inventory short form (BPI), which is commonly used in clinical trials and has documented validity, reliability, and responsiveness to change.
|
At baseline, 3 months, and 6 months post-randomization
|
|
Quality of Life
Periodo de tiempo: At baseline, 3 months, and 6 months post-randomization
|
Investigators will use the Short Form-12 (SF-12)103, a global measure of patient quality of life with well-established psychometrically sound properties across many disease areas and populations, including chronic pain patients.
The SF-12 is responsive to interventions, and is currently being used as the key CPI patient evaluation measure by AMI.
|
At baseline, 3 months, and 6 months post-randomization
|
|
Pain Medication Use
Periodo de tiempo: At baseline, 3 months, and 6 months post-randomization
|
Schedule II/III opioid medication utilization will derive from the RI Department of Health (HEALTH)'s Prescription Monitoring Program (PMP) database.
|
At baseline, 3 months, and 6 months post-randomization
|
|
Likelihood of Misusing Opioid Medication
Periodo de tiempo: At baseline, 3 months, and 6 months post-randomization
|
The SOAPP-R and COMM are quick and easy-to-use, designed to help providers evaluate the patients' relative risk for developing problems when placed on long-term opioid therapy (SOAPP-R) or to monitor chronic pain patients on opioid therapy (COMM).
As a screening tool, the SOAPP-R and the COMM are recommended by SAMHSA in the treatment of chronic pain in patients with histories of or at risk of substance use disorder.
|
At baseline, 3 months, and 6 months post-randomization
|
|
Safety and Aberrant Pain Medication Use Behaviors
Periodo de tiempo: At baseline, 3 months, and 6 month post-randomization
|
Investigators will examine patient ED utilization from the health plans' (UH,NH) claims data and prevalence and incidence of aberrant opioid medication use (i.e.,"dr.
shopping") from the RI PMP database.
|
At baseline, 3 months, and 6 month post-randomization
|
|
Acceptance & Satisfaction
Periodo de tiempo: At 9-month follow up
|
Patients will be asked to rate intervention utility and content (relevance, interest) using 5-point Likert scales.
|
At 9-month follow up
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Traci Green, PhD, MSc, Inflexxion, Inc., Brown University, and Rhode Island Hospital
- Silla de estudio: Megan Ranney, MD, The Miriam Hospital and Brown University
- Silla de estudio: Elizabeth Donovan, PhD, Independent consultant
Publicaciones y enlaces útiles
Enlaces Útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- IHS -1306-02960
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .